论文部分内容阅读
本站采用上海实业科华生物技术有限公司生产C型肝炎抗体试剂盒(ELISA)批号:920220,所含抗原为合成多肽抗原(包含有HCV 病毒结构区核心抗原和非结构区抗原)。从1992年4月～6月对无锡市及丹徒地区2258名献血员(男950,女1308名)进行了抗-HCV 检测,其中无锡市为573名,丹徒地区为1685名。标本为采血前体检时留样。结果显示:抗-HCV 阳性200例,阳性率8.86%,其中男69例(7.26%),女131例(10.0%)。各血型间献血员中,A 型537份血样中抗-HCV 阳性66例占12.3%,B 型485份阳性58例占12.0%,O 型489份阳性56例占11.5%,AB 型174份阳性19例占10.9%,各血型间无差异。城市与农村的献血员抗-HCV 阳性率比较,城市献血员573名,抗-HCV 阳性1例占
This site uses Shanghai Industrial Kehua Biotechnology Co., Ltd. to produce hepatitis C antibody reagent kit (ELISA) lot number: 920220, the antigen contained synthetic peptide antigen (including HCV core antigen structural domain and non-structural antigen). From April to June 1992, 2258 blood donors (male 950 and female 1308) in Wuxi and Dantu areas were tested for anti-HCV, among which 573 were from Wuxi and 1685 from Dantu. Specimens for pre-blood tests before leaving the sample. The results showed that: anti-HCV positive 200 cases, the positive rate of 8.86%, including 69 males (7.26%) and 131 females (10.0%). Of the 53 blood samples of type A, 12 were positive for anti-HCV, 66 were positive for B, 485 were positive, 58 were positive, 58 were positive for type O, 11.5 were positive for 489, and 174 were positive for AB 19 cases accounted for 10.9%, no difference between the various blood groups. Blood donors in urban and rural areas compared with anti-HCV positive rate, 573 city blood donors, anti-HCV positive in 1 case